BioWorld MedTech – Kent Imaging Says its Device is the First Line of Defense in Wound and Tissue Analysis

Whether it’s a chronic wound, acute injury or following surgical intervention, we give physicians the first line of defense to determine if the tissue has a chance to survive and remain viable.


Kent Imaging Revolutionizes Perfusion Imaging with Their FDA Cleared SnapshotNIR

CALGARY, Oct. 19, 2017 /CNW/ – Kent Imaging, a leading provider of near infrared imaging solutions, announced today that the U.S. Food and Drug Administration (FDA) has cleared their multispectral Medical Imaging Device (SnapshotNIR).

Kent’s device is the next step in perfusion imaging by directly showing tissue oxygenation. The SnapshotNIR provides insight into the availability of oxygenated blood in tissue, which enables accurate diagnosis, improved treatment planning and effective patient monitoring.

“Using the Kent camera, we can quantify perfusion directly by determining the ratio of oxygenated to deoxygenated hemoglobin”, said Dr. Adam Landsman, DPM, PhD, Chief of Division of Podiatric Surgery at the Cambridge Health Alliance (Harvard Medical School). Furthermore, because the data can be collected in less than a second, the device can help to quantify the effect of our treatments, and allow us to easily monitor the patient’s condition on a regular basis.”

“We are very excited about obtaining Class II FDA clearance for our handheld device”, said Pierre Lemire, CEO of Kent Imaging. “Our low cost and easy to use device helps physicians to determine the most effective treatment plans which provides them a means of reducing recovery times and patient discomfort.”

Features of Kent’s SnapshotNIR:

  • Instant wound assessment
  • Non-invasive with no injectables or dyes
  • A means to track patient progress and treatment effectiveness
  • Provides quantified tissue oxygenation levels
  • No disruption to existing workflow
  • Accurate, unlimited imaging and storage
  • Ease-of-use with minimal training required
  • Low cost device with no disposables
  • Lightweight portable handheld device

The SnapshotNIR is now available for sale in both the United States and Canada.

About Kent Imaging Inc.

Kent Imaging, located in Calgary, Alberta, Canada, is a leading developer of medical technology, who designs, manufactures and markets imaging technology for wound and surgical care. Kent holds multiple patents in medical technology and continues to provide innovative and advanced diagnostic imaging solutions to aid healthcare systems nationally and internationally. For more information about our company visit us at

Kent Imaging Inc., Vonda-Lee Sharun – Marketing Manager,, Phone: 1.403.605.0230

DOTmed Health Care Business – FDA Gives Green Light to Kent Imaging’s Perfusion Imaging Device, SnapshotNIR

The portable, hand-held device can collect data in less than a second using a variety of health applications, to provide physicians with simplified diagnostic readings and insights for analysis on the best course of treatment before, during and after clinical and surgical care.

Read the full article here